Have a feature idea you'd love to see implemented? Let us know!

CLOV Clover Health Investments Corp

Price (delayed)

$3.36

Market cap

$1.68B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.2

Enterprise value

$1.4B

Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral ...

Highlights
Clover Health Investments's gross margin has surged by 85% YoY
The net income has soared by 60% year-on-year and by 26% since the previous quarter
Clover Health Investments's quick ratio has surged by 53% YoY but it has decreased by 4.2% QoQ
The revenue has contracted by 16% YoY

Key stats

What are the main financial stats of CLOV
Market
Shares outstanding
501.11M
Market cap
$1.68B
Enterprise value
$1.4B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.89
Price to sales (P/S)
1.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.91
Earnings
Revenue
$1.54B
EBIT
-$91.39M
EBITDA
-$89.73M
Free cash flow
-$109.59M
Per share
EPS
-$0.2
Free cash flow per share
-$0.22
Book value per share
$0.69
Revenue per share
$3.15
TBVPS
$1.33
Balance sheet
Total assets
$653.01M
Total liabilities
$310.85M
Debt
$3.67M
Equity
$342.17M
Working capital
$153.09M
Liquidity
Debt to equity
0.01
Current ratio
1.55
Quick ratio
1.38
Net debt/EBITDA
3.17
Margins
EBITDA margin
-5.8%
Gross margin
21.6%
Net margin
-5.9%
Operating margin
-5.8%
Efficiency
Return on assets
-14.2%
Return on equity
-29.3%
Return on invested capital
-75.3%
Return on capital employed
-24.5%
Return on sales
-5.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CLOV stock price

How has the Clover Health Investments stock price performed over time
Intraday
0.3%
1 week
9.09%
1 month
-17.24%
1 year
242.33%
YTD
252.9%
QTD
19.15%

Financial performance

How have Clover Health Investments's revenue and profit performed over time
Revenue
$1.54B
Gross profit
$333.83M
Operating income
-$89.96M
Net income
-$91.39M
Gross margin
21.6%
Net margin
-5.9%
Clover Health Investments's gross margin has surged by 85% YoY
The operating income has soared by 64% YoY and by 22% from the previous quarter
The net income has soared by 60% year-on-year and by 26% since the previous quarter
Clover Health Investments's operating margin has soared by 57% YoY and by 24% from the previous quarter

Growth

What is Clover Health Investments's growth rate over time

Valuation

What is Clover Health Investments stock price valuation
P/E
N/A
P/B
4.89
P/S
1.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.91
CLOV's EPS has surged by 57% year-on-year and by 20% since the previous quarter
The P/B is 122% above the last 4 quarters average of 2.2 but 73% below the 5-year quarterly average of 17.9
The equity has grown by 6% YoY and by 5% from the previous quarter
The P/S is 168% above the last 4 quarters average of 0.4 but 18% below the 5-year quarterly average of 1.3
The revenue has contracted by 16% YoY

Efficiency

How efficient is Clover Health Investments business performance
The return on invested capital has surged by 63% year-on-year and by 35% since the previous quarter
CLOV's ROE has soared by 57% YoY and by 27% from the previous quarter
CLOV's return on sales has surged by 52% year-on-year and by 27% since the previous quarter
The ROA has grown by 28% YoY and by 14% from the previous quarter

Dividends

What is CLOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CLOV.

Financial health

How did Clover Health Investments financials performed over time
CLOV's total assets is 110% greater than its total liabilities
Clover Health Investments's total liabilities has plunged by 58% YoY and by 11% from the previous quarter
Clover Health Investments's quick ratio has surged by 53% YoY but it has decreased by 4.2% QoQ
The debt is 99% less than the equity
The debt to equity has plunged by 50% YoY
The debt has contracted by 26% YoY and by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.